RIVA, MARCELLO
 Distribuzione geografica
Continente #
NA - Nord America 361
EU - Europa 60
AS - Asia 53
Totale 474
Nazione #
US - Stati Uniti d'America 360
CN - Cina 43
DE - Germania 16
IT - Italia 16
FI - Finlandia 11
IN - India 9
GB - Regno Unito 7
SE - Svezia 6
NL - Olanda 3
CA - Canada 1
IL - Israele 1
RU - Federazione Russa 1
Totale 474
Città #
Fairfield 68
Chandler 42
Ashburn 37
Seattle 37
Houston 32
Cambridge 31
Woodbridge 21
Beijing 15
Wilmington 14
Helsinki 10
Padova 8
San Diego 8
Pune 7
Ann Arbor 6
Medford 6
Princeton 6
Des Moines 4
Guangzhou 4
New York 4
Shenyang 4
Amsterdam 3
Miami 3
Nanjing 3
Düsseldorf 2
Kilburn 2
Verona 2
Ahmedabad 1
Belpasso 1
Boardman 1
Bolzano 1
Chongqing 1
Falkenstein 1
Frankfurt Am Main 1
Fuzhou 1
Holon 1
Jinan 1
Lappeenranta 1
Ningbo 1
Norwalk 1
Nutley 1
Phoenix 1
Roxbury 1
Shanghai 1
Toronto 1
Turin 1
Totale 398
Nome #
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: A report of three cases 122
Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients 106
Immunomodulatory drugs in plasma cell diseases: everything has its price 99
A case of “double hit” mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib 50
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms 42
Dealing With High-Risk AL Amyloidosis Patients: A Single Hematologic Center Experience 34
Rituximab and bendamustine (Br) compared with rituximab, bendamustine, and cytarabine (r-bac) in previously untreated elderly patients with mantle cell lymphoma 22
IDH2R172 mutation in angioimmunoblastic T-cell lymphoma: A retrospective multicenter case series 15
Totale 490
Categoria #
all - tutte 2.115
article - articoli 2.115
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.230


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201922 0 0 0 0 0 0 0 0 0 4 9 9
2019/2020131 6 2 5 29 11 9 8 14 9 18 15 5
2020/202187 19 7 13 7 4 0 4 8 15 2 6 2
2021/202285 2 13 13 0 5 3 6 10 3 0 14 16
2022/202383 17 3 1 15 14 10 1 4 9 3 3 3
2023/202468 0 8 5 6 6 24 15 0 0 4 0 0
Totale 490